2m 2m 2m 2m 2m 2m 2m
Ardelyx (ARDX)
NASDAQ
$5.19+$0.05 (+0.93%)
Price as of Jul 14, 2026 6:02 AM EDT- $1.3BMarket Cap
- 11.50%1-Year Change
- BiotechnologyIndustry
Ardelyx (ARDX)
$5.19+$0.05 (+0.93%)
ARDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.14 | ||
Change | -$0.14 (-2.65%) | ||
Open | $5.25 | ||
High | $5.28 | ||
Low | $5.04 | ||
Previous Close | $5.28 | ||
Volume | 2,929,499 | ||
30-Day Average Volume | 4,960,176 | ||
1-Week Change | -3.75% | ||
1-Month Change | -9.67% | ||
1-Year Change | 11.50% | ||
3-Year Change | 48.99% | ||
5-Year Change | -34.69% | ||
Fundamentals | |||
Shares Outstanding | 247.0M | ||
Total Assets | $504.5M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $93.4M | ||
Net Income | -$37.6M | ||
Free Cash Flow | -$32.3M | ||
EBIT | -$37.6M | ||
EBITDA | -$36.7M | ||
Net Working Capital | $272.3M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 9 | ||
P/E | -34 | ||
PEG | 0 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue